The terminal dosage of Chinese medicine remains a steady growth

Feb 23
08:23

2012

David Yvon

David Yvon

  • Share this article on Facebook
  • Share this article on Twitter
  • Share this article on Linkedin

In recent years, SARS, avian flu, hand, and foot-mouth disease occurred in China. In the disease prevention, control and treatment, Chinese medicines undoubtedly played a major role.

mediaimage

People once again look into the field of Chinese medicine. Chinese medicine pays attention to improve body's immune system,The terminal dosage of Chinese medicine remains a steady growth Articles and then kill the virus by the immune system’s strong self-immunity. So that the traditional Chinese medicine can treat and prevent the diseases Anti-inflammatory of traditional Chinese medicine are recognized by medical workers and the masses.

According to recently released data show that the field of Chinese medicine industry has maintained for nearly 10 years of consistently high growth. Chinese pharmaceutical raw materials manufacturing output grew by 25.99 percent in the first half of 2010, industrial sales output value increased by 25.11%, showing the Chinese pharmaceutical industry has shown rapid growth trend. Proprietary Chinese medicines manufacturing output increased by 27.74%, industrial sales output value increased by 27.57%, slightly higher than the growth of the overall pharmaceutical industry.

From the hospital terminal proprietary Chinese data, the terminal dosage of proprietary Chinese medicines also increased steadily. Nine major cities medicines market total purchases in the first half of last year, an increase of 22.58%, slightly higher than the growth rate of 22.43% in the same period last year. Growth in the nine urban hospitals, purchases of proprietary Chinese medicines from 4.15 billion RMB in the first half of 2007 to 7.5 billion RMB in the first half of last year, the compound annual growth rate of 21.79%, higher than 20% growth each year.

The view from each of the categories, respiratory system diseases, drugs, pediatric drugs, nervous system disease medication in the first half of this year from a year earlier rapid growth. Tumor diseases, docetaxel drug use, cardiovascular disease medication to maintain double-digit growth, but growth are below average.

With the gradual development of China's economic level, people's livings standards continue to improve gradually improve people's health awareness, health insurance to cover large areas, the rapid expansion of demand for health care. Advance by the Chinese government this year restructuring and adjustment, to encourage domestic demand and the gradual implementation of new medical reform measures, coupled with the transfer of international pharmaceutical manufacturing industry to China, China's pharmaceutical industry continued to show rapid growth.

On the other hand, as the Chinese government‘s strict control on the pharmaceutical industry in recent years, the pharmaceutical industry matures and the pharmaceutical industry production capacity gradually expands. The pharmaceutical industry steps into rapid development of the golden years. In the next 10 years, Chinese pharmaceutical industry will remain at 20% or higher level development rate. In 2020, the country will become the second drug consuming country after United States. The development of Chinese medicines market will benefit from it.

Source:http://www.cospcn.com